EXAGEN PARTNERS WITH WESTWOOD & WILSHIRE TO PLACE CHIEF MEDICAL OFFICER

Exagen Diagnostics Inc. – a life sciences company working to aid providers in the proper diagnosis, prognosis, and management of autoimmune conditions – has hired Dr. Debra Zack as the new Chief Medical Officer. Prior to joining Exagen, Dr. Zack served as VP of Clinical Development at Xencor and previously held leadership roles at Novartis Biotherapeutics and Amgen.  After obtaining her MD/PhD in Immunology Medicine, Dr. Zack also served as an Associate Professor of Medicine at UCLA Medical School. 

The search was successfully led by Julie McDonald for Westwood & Wilshire’s Life Science’s practice.

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Our firm has offices in Los Angeles, Silicon Valley, and Seattle, serving clients on a local, national and global basis.